<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38542177</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3203</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25063203</ELocationID><Abstract><AbstractText>Mental disorders account for one of the most prevalent categories of the burden of disease worldwide, with depression expected to be the largest contributor by 2030, closely followed by anxiety. The COVID-19 pandemic possibly exacerbated these challenges, especially amongst adolescents, who experienced isolation, disrupted routines, and limited healthcare access. Notably, the pandemic has been associated with long-term neurological effects known as "long-COVID", characterized by both cognitive and psychopathological symptoms. In general, psychiatric disorders, including those related to long-COVID, are supposed to be due to widespread inflammation leading to neuroinflammation. Recently, the endocannabinoid system (ECS) emerged as a potential target for addressing depression and anxiety pathophysiology. Specifically, natural or synthetic cannabinoids, able to selectively interact with cannabinoid type-2 receptor (CB2R), recently revealed new therapeutic potential in neuropsychiatric disorders with limited or absent psychotropic activity. Among the most promising natural CB2R ligands, the bicyclic sesquiterpene &#x3b2;-caryophyllene (BCP) has emerged as an excellent anti-inflammatory and antioxidant therapeutic agent. This review underscores BCP's immunomodulatory and anti-inflammatory properties, highlighting its therapeutic potential for the management of depression and anxiety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ricardi</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barachini</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4972-7927</Identifier><AffiliationInfo><Affiliation>Hematology Division, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Consoli</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marazziti</LastName><ForeName>Donatella</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4021-5829</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniCamillus, Saint Camillus International University of Health and Medical Sciences, 00151 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polini</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2664-6091</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiellini</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6703-5820</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>BHW853AU9H</RegistryNumber><NameOfSubstance UI="C024714">caryophyllene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063386">Cannabinoid Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043882">Receptors, Cannabinoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043885">Receptor, Cannabinoid, CB2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000081223">Polycyclic Sesquiterpenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063386" MajorTopicYN="Y">Cannabinoid Receptor Agonists</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043882" MajorTopicYN="N">Receptors, Cannabinoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043885" MajorTopicYN="N">Receptor, Cannabinoid, CB2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081223" MajorTopicYN="Y">Polycyclic Sesquiterpenes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">cannabinoid type 2 receptor</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">endocannabinoid system</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuropsychiatric diseases</Keyword><Keyword MajorTopicYN="N">&#x3b2;-caryophyllene</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38542177</ArticleId><ArticleId IdType="pmc">PMC10970213</ArticleId><ArticleId IdType="doi">10.3390/ijms25063203</ArticleId><ArticleId IdType="pii">ijms25063203</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., et al. Global Burden of Disease Attributable to Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575&#x2013;1586. doi: 10.1016/S0140-6736(13)61611-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61611-6</ArticleId><ArticleId IdType="pubmed">23993280</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Arlington, VA, USA: 2013.</Citation></Reference><Reference><Citation>Marazziti D., Avella M.T., Mucci N., Della Vecchia A., Ivaldi T., Palermo S., Mucci F. Impact of Economic Crisis on Mental Health: A 10-Year Challenge. CNS Spectr. 2021;26:7&#x2013;13. doi: 10.1017/S1092852920000140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1092852920000140</ArticleId><ArticleId IdType="pubmed">32252843</ArticleId></ArticleIdList></Reference><Reference><Citation>Fountoulakis K.N., Karakatsoulis G., Abraham S., Adorjan K., Ahmed H.U., Alarc&#xf3;n R.D., Arai K., Auwal S.S., Berk M., Bjedov S., et al. Results of the COVID-19 Mental Health International for the General Population (COMET-G) Study. Eur. Neuropsychopharmacol. 2022;54:21&#x2013;40. doi: 10.1016/j.euroneuro.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8609892</ArticleId><ArticleId IdType="pubmed">34758422</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones E.A.K., Mitra A.K., Bhuiyan A.R. Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review. Int. J. Environ. Res. Public Health. 2021;18:2470. doi: 10.3390/ijerph18052470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052470</ArticleId><ArticleId IdType="pmc">PMC7967607</ArticleId><ArticleId IdType="pubmed">33802278</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvi T., Kumar D., Tabak B.A. Social Anxiety and Behavioral Assessments of Social Cognition: A Systematic Review. J. Affect. Disord. 2022;311:17&#x2013;30. doi: 10.1016/j.jad.2022.04.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.04.130</ArticleId><ArticleId IdType="pmc">PMC9754122</ArticleId><ArticleId IdType="pubmed">35490878</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith D.R., Bekhbat M., Mehta N.D., Felger J.C. Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology. Biol. Psychiatry. 2023;93:405&#x2013;418. doi: 10.1016/j.biopsych.2022.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2022.11.003</ArticleId><ArticleId IdType="pmc">PMC9895884</ArticleId><ArticleId IdType="pubmed">36725140</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveros M.P., Marco E.M., File S.E. Endocannabinoid System and Stress and Anxiety Responses. Pharmacol. Biochem. Behav. 2005;81:331&#x2013;342. doi: 10.1016/j.pbb.2005.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbb.2005.01.029</ArticleId><ArticleId IdType="pubmed">15927244</ArticleId></ArticleIdList></Reference><Reference><Citation>Riebe C.J., Pamplona F.A., Kamprath K., Wotjak C.T. Fear Relief-toward a New Conceptual Frame Work and What Endocannabinoids Gotta Do with It. Neuroscience. 2012;204:159&#x2013;185. doi: 10.1016/j.neuroscience.2011.11.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.11.057</ArticleId><ArticleId IdType="pubmed">22173015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruehle S., Rey A.A., Remmers F., Lutz B. The Endocannabinoid System in Anxiety, Fear Memory and Habituation. J. Psychopharmacol. 2012;26:23&#x2013;39. doi: 10.1177/0269881111408958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881111408958</ArticleId><ArticleId IdType="pmc">PMC3267552</ArticleId><ArticleId IdType="pubmed">21768162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluett R.J., Gamble-George J.C., Hermanson D.J., Hartley N.D., Marnett L.J., Patel S. Central Anandamide Deficiency Predicts Stress-Induced Anxiety: Behavioral Reversal through Endocannabinoid Augmentation. Transl. Psychiatry. 2014;4:e408. doi: 10.1038/tp.2014.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2014.53</ArticleId><ArticleId IdType="pmc">PMC4119220</ArticleId><ArticleId IdType="pubmed">25004388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunduz-Cinar O., MacPherson K.P., Cinar R., Gamble-George J., Sugden K., Williams B., Godlewski G., Ramikie T.S., Gorka A.X., Alapafuja S.O., et al. Convergent Translational Evidence of a Role for Anandamide in Amygdala-Mediated Fear Extinction, Threat Processing and Stress-Reactivity. Mol. Psychiatry. 2013;18:813&#x2013;823. doi: 10.1038/mp.2012.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.72</ArticleId><ArticleId IdType="pmc">PMC3549323</ArticleId><ArticleId IdType="pubmed">22688188</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray J.M., Vecchiarelli H.A., Morena M., Lee T.T.Y., Hermanson D.J., Kim A.B., McLaughlin R.J., Hassan K.I., K&#xfc;hne C., Wotjak C.T., et al. Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety. J. Neurosci. 2015;35:3879&#x2013;3892. doi: 10.1523/JNEUROSCI.2737-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2737-14.2015</ArticleId><ArticleId IdType="pmc">PMC4348185</ArticleId><ArticleId IdType="pubmed">25740517</ArticleId></ArticleIdList></Reference><Reference><Citation>Akirav I. The Role of Cannabinoids in Modulating Emotional and Non-Emotional Memory Processes in the Hippocampus. Front. Behav. Neurosci. 2011;5:34. doi: 10.3389/fnbeh.2011.00034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2011.00034</ArticleId><ArticleId IdType="pmc">PMC3124830</ArticleId><ArticleId IdType="pubmed">21734875</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadijan A., Vla&#x161;i&#x107; I., Vlaini&#x107; J., &#x110;iki&#x107; D., Or&#x161;oli&#x107; N., Jazvin&#x161;&#x107;ak Jembrek M. Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions. Antioxidants. 2022;11:2049. doi: 10.3390/antiox11102049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11102049</ArticleId><ArticleId IdType="pmc">PMC9598923</ArticleId><ArticleId IdType="pubmed">36290771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Gao M., Gao F., Su Q., Wu J. Brain Cannabinoid Receptor 2: Expression, Function and Modulation. Acta Pharmacol. Sin. 2017;38:312&#x2013;316. doi: 10.1038/aps.2016.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2016.149</ArticleId><ArticleId IdType="pmc">PMC5342669</ArticleId><ArticleId IdType="pubmed">28065934</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi N., Onaivi E.S. Endocannabinoid System Components: Overview and Tissue Distribution. Adv. Exp. Med. Biol. 2019;1162:1&#x2013;12. doi: 10.1007/978-3-030-21737-2_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-21737-2_1</ArticleId><ArticleId IdType="pubmed">31332731</ArticleId></ArticleIdList></Reference><Reference><Citation>Morcuende A., Garc&#xed;a-Guti&#xe9;rrez M.S., Tambaro S., Nieto E., Manzanares J., Femenia T. Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders. Front. Psychiatry. 2022;13:866052. doi: 10.3389/fpsyt.2022.866052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.866052</ArticleId><ArticleId IdType="pmc">PMC9051035</ArticleId><ArticleId IdType="pubmed">35492718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashiesh H.M., Sharma C., Goyal S.N., Sadek B., Jha N.K., Kaabi J.A., Ojha S. A Focused Review on CB2 Receptor-Selective Pharmacological Properties and Therapeutic Potential of &#x3b2;-Caryophyllene, a Dietary Cannabinoid. Biomed. Pharmacother. 2021;140:111639. doi: 10.1016/j.biopha.2021.111639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111639</ArticleId><ArticleId IdType="pubmed">34091179</ArticleId></ArticleIdList></Reference><Reference><Citation>Scandiffio R., Geddo F., Cottone E., Querio G., Antoniotti S., Gallo M.P., Maffei M.E., Bovolin P. Protective Effects of (E)-&#x3b2;-Caryophyllene (BCP) in Chronic Inflammation. Nutrients. 2020;12:3273. doi: 10.3390/nu12113273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113273</ArticleId><ArticleId IdType="pmc">PMC7692661</ArticleId><ArticleId IdType="pubmed">33114564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferber S.G., Namdar D., Hen-Shoval D., Eger G., Koltai H., Shoval G., Shbiro L., Weller A. The &#x201c;Entourage Effect&#x201d;: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Curr. Neuropharmacol. 2020;18:87&#x2013;96. doi: 10.2174/1570159X17666190903103923.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X17666190903103923</ArticleId><ArticleId IdType="pmc">PMC7324885</ArticleId><ArticleId IdType="pubmed">31481004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathod S.S., Agrawal Y.O., Nakhate K.T., Meeran M.F.N., Ojha S., Goyal S.N. Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System. Biomedicines. 2023;11:2642. doi: 10.3390/biomedicines11102642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11102642</ArticleId><ArticleId IdType="pmc">PMC10604915</ArticleId><ArticleId IdType="pubmed">37893016</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito C., Tol&#xf3;n R.M., Pazos M.R., N&#xfa;&#xf1;ez E., Castillo A.I., Romero J. Cannabinoid CB2 Receptors in Human Brain Inflammation. Br. J. Pharmacol. 2008;153:277&#x2013;285. doi: 10.1038/sj.bjp.0707505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0707505</ArticleId><ArticleId IdType="pmc">PMC2219537</ArticleId><ArticleId IdType="pubmed">17934510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernang&#xf3;mez M., Mestre L., Correa F.G., Lor&#xed;a F., Mecha M., I&#xf1;igo P.M., Docagne F., Williams R.O., Borrell J., Guaza C. CD200-CD200R1 Interaction Contributes to Neuroprotective Effects of Anandamide on Experimentally Induced Inflammation. Glia. 2012;60:1437&#x2013;1450. doi: 10.1002/glia.22366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22366</ArticleId><ArticleId IdType="pubmed">22653796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M.E., Teixeira A.L. Inflammation in Psychiatric Disorders: What Comes First? Ann. N. Y. Acad. Sci. 2019;1437:57&#x2013;67. doi: 10.1111/nyas.13712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13712</ArticleId><ArticleId IdType="pubmed">29752710</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom S., Persidsky Y. Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation. J. Neuroimmune Pharmacol. 2013;8:608&#x2013;620. doi: 10.1007/s11481-013-9445-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9445-9</ArticleId><ArticleId IdType="pmc">PMC3663904</ArticleId><ArticleId IdType="pubmed">23471521</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo K., Mou X., Huang J., Xiong N., Li H. Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-&#x3ba;B Activation in Microglia. J. Mol. Neurosci. 2014;54:41&#x2013;48. doi: 10.1007/s12031-014-0243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0243-5</ArticleId><ArticleId IdType="pubmed">24488604</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng W.S., Hu S., Min X., Cabral G.A., Lokensgard J.R., Peterson P.K. Synthetic Cannabinoid WIN55,212-2 Inhibits Generation of Inflammatory Mediators by IL-1beta-Stimulated Human Astrocytes. Glia. 2005;49:211&#x2013;219. doi: 10.1002/glia.20108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20108</ArticleId><ArticleId IdType="pubmed">15390091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y., Deng H., Qin Q., Ma Z. JWH133 Inhibits MPP+-Induced Inflammatory Response and Iron Influx in Astrocytes. Neurosci. Lett. 2020;720:134779. doi: 10.1016/j.neulet.2020.134779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.134779</ArticleId><ArticleId IdType="pubmed">31981721</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkaitis M.S., Solorzano C., Landry R.P., Piomelli D., DeLeo J.A., Romero-Sandoval E.A. Evidence for a Role of Endocannabinoids, Astrocytes and P38 Phosphorylation in the Resolution of Postoperative Pain. PLoS ONE. 2010;5:e10891. doi: 10.1371/journal.pone.0010891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010891</ArticleId><ArticleId IdType="pmc">PMC2878341</ArticleId><ArticleId IdType="pubmed">20531936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng W.S., Hu S., Ni H.T., Rock R.B., Peterson P.K. WIN55,212-2 Inhibits Production of CX3CL1 by Human Astrocytes: Involvement of P38 MAP Kinase. J. Neuroimmune Pharmacol. 2009;4:244&#x2013;248. doi: 10.1007/s11481-009-9147-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9147-5</ArticleId><ArticleId IdType="pmc">PMC2729711</ArticleId><ArticleId IdType="pubmed">19214751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing N., Fang B., Li Z., Tian A. Exogenous Activation of Cannabinoid-2 Receptor Modulates TLR4/MMP9 Expression in a Spinal Cord Ischemia Reperfusion Rat Model. J. Neuroinflamm. 2020;17:101. doi: 10.1186/s12974-020-01784-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01784-7</ArticleId><ArticleId IdType="pmc">PMC7132899</ArticleId><ArticleId IdType="pubmed">32248810</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchalant Y., Brothers H.M., Norman G.J., Karelina K., DeVries A.C., Wenk G.L. Cannabinoids Attenuate the Effects of Aging upon Neuroinflammation and Neurogenesis. Neurobiol. Dis. 2009;34:300&#x2013;307. doi: 10.1016/j.nbd.2009.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.01.014</ArticleId><ArticleId IdType="pubmed">19385063</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazuelos J., Ortega Z., D&#xed;az-Alonso J., Guzm&#xe1;n M., Galve-Roperh I. CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling. J. Biol. Chem. 2012;287:1198&#x2013;1209. doi: 10.1074/jbc.M111.291294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.291294</ArticleId><ArticleId IdType="pmc">PMC3256884</ArticleId><ArticleId IdType="pubmed">22102284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro H., Kibret B.G., Horiuchi Y., Onaivi E.S. Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders. Front. Psychiatry. 2022;13:828895. doi: 10.3389/fpsyt.2022.828895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.828895</ArticleId><ArticleId IdType="pmc">PMC9237241</ArticleId><ArticleId IdType="pubmed">35774086</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco E.M., Echeverry-Alzate V., L&#xf3;pez-Moreno J.A., Gin&#xe9; E., Pe&#xf1;asco S., Viveros M.P. Consequences of Early Life Stress on the Expression of Endocannabinoid-Related Genes in the Rat Brain. Behav. Pharmacol. 2014;25:547&#x2013;556. doi: 10.1097/FBP.0000000000000068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FBP.0000000000000068</ArticleId><ArticleId IdType="pubmed">25083571</ArticleId></ArticleIdList></Reference><Reference><Citation>Onaivi E.S., Ishiguro H., Gong J.-P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E., et al. Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression. Ann. N. Y. Acad. Sci. 2008;1139:434&#x2013;449. doi: 10.1196/annals.1432.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1432.036</ArticleId><ArticleId IdType="pmc">PMC3922202</ArticleId><ArticleId IdType="pubmed">18991891</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Guti&#xe9;rrez M.S., Navarrete F., Navarro G., Reyes-Resina I., Franco R., Lanciego J.L., Giner S., Manzanares J. Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims. Neurotherapeutics. 2018;15:796&#x2013;806. doi: 10.1007/s13311-018-0610-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0610-y</ArticleId><ArticleId IdType="pmc">PMC6095782</ArticleId><ArticleId IdType="pubmed">29435814</ArticleId></ArticleIdList></Reference><Reference><Citation>Onaivi E.S., Ishiguro H., Gong J.-P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E., et al. Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects. PLoS ONE. 2008;3:e1640. doi: 10.1371/journal.pone.0001640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001640</ArticleId><ArticleId IdType="pmc">PMC2241668</ArticleId><ArticleId IdType="pubmed">18286196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Alvaro A., Aracil-Fern&#xe1;ndez A., Garc&#xed;a-Guti&#xe9;rrez M.S., Navarrete F., Manzanares J. Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice. Neuropsychopharmacology. 2011;36:1489&#x2013;1504. doi: 10.1038/npp.2011.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2011.34</ArticleId><ArticleId IdType="pmc">PMC3096817</ArticleId><ArticleId IdType="pubmed">21430651</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A.H., Raison C.L. The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target. Nat. Rev. Immunol. 2016;16:22&#x2013;34. doi: 10.1038/nri.2015.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.5</ArticleId><ArticleId IdType="pmc">PMC5542678</ArticleId><ArticleId IdType="pubmed">26711676</ArticleId></ArticleIdList></Reference><Reference><Citation>Roohi E., Jaafari N., Hashemian F. On Inflammatory Hypothesis of Depression: What Is the Role of IL-6 in the Middle of the Chaos? J. Neuroinflamm. 2021;18:45. doi: 10.1186/s12974-021-02100-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02100-7</ArticleId><ArticleId IdType="pmc">PMC7884972</ArticleId><ArticleId IdType="pubmed">33593388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Xiao L., Wang H., Wang G. Neurogenic Hypothesis of Positive Psychology in Stress-Induced Depression: Adult Hippocampal Neurogenesis, Neuroinflammation, and Stress Resilience. Int. Immunopharmacol. 2021;97:107653. doi: 10.1016/j.intimp.2021.107653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107653</ArticleId><ArticleId IdType="pubmed">33915495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming Z., Sawicki G., Bekar L.K. Acute Systemic LPS-Mediated Inflammation Induces Lasting Changes in Mouse Cortical Neuromodulation and Behavior. Neurosci. Lett. 2015;590:96&#x2013;100. doi: 10.1016/j.neulet.2015.01.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.01.081</ArticleId><ArticleId IdType="pubmed">25650524</ArticleId></ArticleIdList></Reference><Reference><Citation>Casaril A.M., Domingues M., Fronza M., Vieira B., Begnini K., Lenard&#xe3;o E.J., Seixas F.K., Collares T., Nogueira C.W., Savegnago L. Antidepressant-like Effect of a New Selenium-Containing Compound Is Accompanied by a Reduction of Neuroinflammation and Oxidative Stress in Lipopolysaccharide-Challenged Mice. J. Psychopharmacol. 2017;31:1263&#x2013;1273. doi: 10.1177/0269881117711713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881117711713</ArticleId><ArticleId IdType="pubmed">28661258</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor J.C., Lawson M.A., Andr&#xe9; C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-Induced Depressive-like Behavior Is Mediated by Indoleamine 2,3-Dioxygenase Activation in Mice. Mol. Psychiatry. 2009;14:511&#x2013;522. doi: 10.1038/sj.mp.4002148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4002148</ArticleId><ArticleId IdType="pmc">PMC2683474</ArticleId><ArticleId IdType="pubmed">18195714</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle S.J., Marciano-Cabral F., Staab A., Ludwick C., Cabral G.A. Differential Expression of the CB2 Cannabinoid Receptor by Rodent Macrophages and Macrophage-like Cells in Relation to Cell Activation. Int. Immunopharmacol. 2002;2:69&#x2013;82. doi: 10.1016/S1567-5769(01)00147-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1567-5769(01)00147-3</ArticleId><ArticleId IdType="pubmed">11789671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lataliza A.A.B., de Assis P.M., da Rocha Laurindo L., Gon&#xe7;alves E.C.D., Raposo N.R.B., Dutra R.C. Antidepressant-like Effect of Rosmarinic Acid during LPS-Induced Neuroinflammatory Model: The Potential Role of Cannabinoid Receptors/PPAR-&#x3b3; Signaling Pathway. Phytother. Res. 2021;35:6974&#x2013;6989. doi: 10.1002/ptr.7318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7318</ArticleId><ArticleId IdType="pubmed">34709695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu P., Mudgal J., Arora D., Kinra M., Mallik S.B., Rao C.M., Pai K.S.R., Nampoothiri M. Cannabinoid Receptor 2 Activation Mitigates Lipopolysaccharide-Induced Neuroinflammation and Sickness Behavior in Mice. Psychopharmacology. 2019;236:1829&#x2013;1838. doi: 10.1007/s00213-019-5166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-019-5166-y</ArticleId><ArticleId IdType="pubmed">30666359</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche M., Diamond M., Kelly J.P., Finn D.P. In Vivo Modulation of LPS-Induced Alterations in Brain and Peripheral Cytokines and HPA Axis Activity by Cannabinoids. J. Neuroimmunol. 2006;181:57&#x2013;67. doi: 10.1016/j.jneuroim.2006.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2006.08.001</ArticleId><ArticleId IdType="pubmed">17011047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoppi S., Madrigal J.L., Caso J.R., Garc&#xed;a-Guti&#xe9;rrez M.S., Manzanares J., Leza J.C., Garc&#xed;a-Bueno B. Regulatory Role of the Cannabinoid CB2 Receptor in Stress-Induced Neuroinflammation in Mice. Br. J. Pharmacol. 2014;171:2814&#x2013;2826. doi: 10.1111/bph.12607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12607</ArticleId><ArticleId IdType="pmc">PMC4243857</ArticleId><ArticleId IdType="pubmed">24467609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrapani S., Eskander N., De Los Santos L.A., Omisore B.A., Mostafa J.A. Neuroplasticity and the Biological Role of Brain Derived Neurotrophic Factor in the Pathophysiology and Management of Depression. Cureus. 2020;12:e11396. doi: 10.7759/cureus.11396.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11396</ArticleId><ArticleId IdType="pmc">PMC7725195</ArticleId><ArticleId IdType="pubmed">33312794</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter G.A., O&#x2019;Connor J.C. Brain-Derived Neurotrophic Factor and Inflammation in Depression: Pathogenic Partners in Crime? World J. Psychiatry. 2022;12:77&#x2013;97. doi: 10.5498/wjp.v12.i1.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v12.i1.77</ArticleId><ArticleId IdType="pmc">PMC8783167</ArticleId><ArticleId IdType="pubmed">35111580</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Guti&#xe9;rrez M.S., Ortega-&#xc1;lvaro A., Busquets-Garc&#xed;a A., P&#xe9;rez-Ortiz J.M., Caltana L., Ricatti M.J., Brusco A., Maldonado R., Manzanares J. Synaptic Plasticity Alterations Associated with Memory Impairment Induced by Deletion of CB2 Cannabinoid Receptors. Neuropharmacology. 2013;73:388&#x2013;396. doi: 10.1016/j.neuropharm.2013.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2013.05.034</ArticleId><ArticleId IdType="pubmed">23796670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Miao H., Jiang B., Chen Q., Tan L., Tao Y., Zhang J., Gao F., Feng H., Zhu G., et al. A Selective CB2R Agonist (JWH133) Restores Neuronal Circuit after Germinal Matrix Hemorrhage in the Preterm via CX3CR1+ Microglia. Neuropharmacology. 2017;119:157&#x2013;169. doi: 10.1016/j.neuropharm.2017.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.01.027</ArticleId><ArticleId IdType="pubmed">28153531</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Guti&#xe9;rrez M.S., P&#xe9;rez-Ortiz J.M., Guti&#xe9;rrez-Ad&#xe1;n A., Manzanares J. Depression-Resistant Endophenotype in Mice Overexpressing Cannabinoid CB2 Receptors. Br. J. Pharmacol. 2010;160:1773&#x2013;1784. doi: 10.1111/j.1476-5381.2010.00819.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.00819.x</ArticleId><ArticleId IdType="pmc">PMC2936848</ArticleId><ArticleId IdType="pubmed">20649579</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente-Berzal A., Assis M.A., Rubino T., Zamberletti E., Marco E.M., Parolaro D., Ambrosio E., Viveros M.-P. Sex-Dependent Changes in Brain CB1R Expression and Functionality and Immune CB2R Expression as a Consequence of Maternal Deprivation and Adolescent Cocaine Exposure. Pharmacol. Res. 2013;74:23&#x2013;33. doi: 10.1016/j.phrs.2013.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2013.05.001</ArticleId><ArticleId IdType="pubmed">23680694</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J.M., Achua J.K., Smith J.P., Prince M.A., Staton C.D., Ronan P.J., Summers T.R., Summers C.H. Anxious Behavior Induces Elevated Hippocampal Cb2 Receptor Gene Expression. Neuroscience. 2017;352:273&#x2013;284. doi: 10.1016/j.neuroscience.2017.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.03.061</ArticleId><ArticleId IdType="pmc">PMC5482502</ArticleId><ArticleId IdType="pubmed">28392296</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Guti&#xe9;rrez M.S., Manzanares J. Overexpression of CB2 Cannabinoid Receptors Decreased Vulnerability to Anxiety and Impaired Anxiolytic Action of Alprazolam in Mice. J. Psychopharmacol. 2011;25:111&#x2013;120. doi: 10.1177/0269881110379507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881110379507</ArticleId><ArticleId IdType="pubmed">20837564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahi A., Al Mansouri S., Al Memari E., Al Ameri M., Nurulain S.M., Ojha S. &#x3b2;-Caryophyllene, a CB2 Receptor Agonist Produces Multiple Behavioral Changes Relevant to Anxiety and Depression in Mice. Physiol. Behav. 2014;135:119&#x2013;124. doi: 10.1016/j.physbeh.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2014.06.003</ArticleId><ArticleId IdType="pubmed">24930711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivy D., Palese F., Vozella V., Fotio Y., Yalcin A., Ramirez G., Mears D., Wynn G., Piomelli D. Cannabinoid CB2 Receptors Mediate the Anxiolytic-like Effects of Monoacylglycerol Lipase Inhibition in a Rat Model of Predator-Induced Fear. Neuropsychopharmacology. 2020;45:1330&#x2013;1338. doi: 10.1038/s41386-020-0696-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-020-0696-x</ArticleId><ArticleId IdType="pmc">PMC7298057</ArticleId><ArticleId IdType="pubmed">32375160</ArticleId></ArticleIdList></Reference><Reference><Citation>Papagianni E.P., Stevenson C.W. Cannabinoid Regulation of Fear and Anxiety: An Update. Curr. Psychiatry Rep. 2019;21:38. doi: 10.1007/s11920-019-1026-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-019-1026-z</ArticleId><ArticleId IdType="pmc">PMC6486906</ArticleId><ArticleId IdType="pubmed">31030284</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazziti D., Carmassi C., Cappellato G., Chiarantini I., Massoni L., Mucci F., Arone A., Violi M., Palermo S., De Iorio G., et al. Novel Pharmacological Targets of Post-Traumatic Stress Disorders. Life. 2023;13:1731. doi: 10.3390/life13081731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13081731</ArticleId><ArticleId IdType="pmc">PMC10455314</ArticleId><ArticleId IdType="pubmed">37629588</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett A.C., Abood M.E. CB1 and CB2 Receptor Pharmacology. Adv. Pharmacol. 2017;80:169&#x2013;206. doi: 10.1016/bs.apha.2017.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.apha.2017.03.007</ArticleId><ArticleId IdType="pmc">PMC5812699</ArticleId><ArticleId IdType="pubmed">28826534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A., Samieipoor Y., Nayeri F.S., Rahbarimanesh A.A., Izadi A., Rashidi-Nezhad A., Tavakoli-Yaraki M., Farahmand M., Bont L., Shokri F., et al. Effects of Cannabinoid Receptor Type 2 in Respiratory Syncytial Virus Infection in Human Subjects and Mice. Virulence. 2018;9:217&#x2013;230. doi: 10.1080/21505594.2017.1389369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1389369</ArticleId><ArticleId IdType="pmc">PMC5955186</ArticleId><ArticleId IdType="pubmed">28992427</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantino C.M., Gupta A., Yewdall A.W., Dale B.M., Devi L.A., Chen B.K. Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells. PLoS ONE. 2012;7:e33961. doi: 10.1371/journal.pone.0033961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033961</ArticleId><ArticleId IdType="pmc">PMC3309010</ArticleId><ArticleId IdType="pubmed">22448282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez S.H., Reichenbach N.L., Fan S., Rom S., Merkel S.F., Wang X., Ho W.-Z., Persidsky Y. Attenuation of HIV-1 Replication in Macrophages by Cannabinoid Receptor 2 Agonists. J. Leukoc. Biol. 2013;93:801&#x2013;810. doi: 10.1189/jlb.1012523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1012523</ArticleId><ArticleId IdType="pmc">PMC3629438</ArticleId><ArticleId IdType="pubmed">23463725</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari V.R., Baradaran Rahimi V., Tabatabaee S.A., Shafiee-Nick R. Combination of Imipramine, a Sphingomyelinase Inhibitor, and &#x3b2;-Caryophyllene Improve Their Therapeutic Effects on Experimental Autoimmune Encephalomyelitis (EAE) Int. Immunopharmacol. 2019;77:105923. doi: 10.1016/j.intimp.2019.105923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105923</ArticleId><ArticleId IdType="pubmed">31711937</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti T.B., Barbosa W.L.R., Vieira J.L.F., Raposo N.R.B., Dutra R.C. (-)-&#x3b2;-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis. Int. J. Mol. Sci. 2017;18:691. doi: 10.3390/ijms18040691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18040691</ArticleId><ArticleId IdType="pmc">PMC5412277</ArticleId><ArticleId IdType="pubmed">28368293</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho C.E.S., Sobrinho-Junior E.P.C., Brito L.M., Nicolau L.a.D., Carvalho T.P., Moura A.K.S., Rodrigues K.a.F., Carneiro S.M.P., Arcanjo D.D.R., Cit&#xf3; A.M.G.L., et al. Anti-Leishmania Activity of Essential Oil of Myracrodruon Urundeuva (Engl.) Fr. All.: Composition, Cytotoxity and Possible Mechanisms of Action. Exp. Parasitol. 2017;175:59&#x2013;67. doi: 10.1016/j.exppara.2017.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exppara.2017.02.012</ArticleId><ArticleId IdType="pubmed">28189487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku C.-M., Lin J.-Y. Anti-Inflammatory Effects of 27 Selected Terpenoid Compounds Tested through Modulating Th1/Th2 Cytokine Secretion Profiles Using Murine Primary Splenocytes. Food Chem. 2013;141:1104&#x2013;1113. doi: 10.1016/j.foodchem.2013.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2013.04.044</ArticleId><ArticleId IdType="pubmed">23790892</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito L.F., Oliveira H.B.M., das Neves Selis N., E Souza C.L.S., J&#xfa;nior M.N.S., de Souza E.P., da Silva L.S.C., de Souza Nascimento F., Amorim A.T., Campos G.B., et al. Anti-Inflammatory Activity of &#x3b2;-Caryophyllene Combined with Docosahexaenoic Acid in a Model of Sepsis Induced by Staphylococcus Aureus in Mice. J. Sci. Food Agric. 2019;99:5870&#x2013;5880. doi: 10.1002/jsfa.9861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jsfa.9861</ArticleId><ArticleId IdType="pubmed">31206687</ArticleId></ArticleIdList></Reference><Reference><Citation>Toguri J.T., Moxsom R., Szczesniak A.M., Zhou J., Kelly M.E.M., Lehmann C. Cannabinoid 2 Receptor Activation Reduces Leukocyte Adhesion and Improves Capillary Perfusion in the Iridial Microvasculature during Systemic Inflammation. Clin. Hemorheol. Microcirc. 2015;61:237&#x2013;249. doi: 10.3233/CH-151996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-151996</ArticleId><ArticleId IdType="pubmed">26410875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardinha J., Kelly M.E.M., Zhou J., Lehmann C. Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis. Mediat. Inflamm. 2014;2014:978678. doi: 10.1155/2014/978678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/978678</ArticleId><ArticleId IdType="pmc">PMC3997158</ArticleId><ArticleId IdType="pubmed">24803745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., An R., Tian X., Yang M., Li M., Lou J., Xu L., Dong Z. &#x3b2;-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway. Neurochem. Res. 2017;42:1459&#x2013;1469. doi: 10.1007/s11064-017-2202-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2202-3</ArticleId><ArticleId IdType="pubmed">28236211</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X., Liu H., Xiang F., Xu L., Dong Z. &#x3b2;-Caryophyllene Protects against Ischemic Stroke by Promoting Polarization of Microglia toward M2 Phenotype via the TLR4 Pathway. Life Sci. 2019;237:116915. doi: 10.1016/j.lfs.2019.116915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116915</ArticleId><ArticleId IdType="pubmed">31610207</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I.-Y., Ju C., Anthony Jalin A.M.A., Lee D.I., Prather P.L., Kim W.-K. Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury. Am. J. Pathol. 2013;182:928&#x2013;939. doi: 10.1016/j.ajpath.2012.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.11.024</ArticleId><ArticleId IdType="pubmed">23414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J., Cao G., Li R., Liu J., Dong Z., Xu L. &#x3b2;-Caryophyllene Attenuates Focal Cerebral Ischemia-Reperfusion Injury by Nrf2/HO-1 Pathway in Rats. Neurochem. Res. 2016;41:1291&#x2013;1304. doi: 10.1007/s11064-016-1826-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-016-1826-z</ArticleId><ArticleId IdType="pubmed">26801169</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyganowska-Swiatkowska M., Nohawica M., Grocholewicz K., Nowak G. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review. Int. J. Mol. Sci. 2020;21:4639. doi: 10.3390/ijms21134639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21134639</ArticleId><ArticleId IdType="pmc">PMC7370028</ArticleId><ArticleId IdType="pubmed">32629817</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan S.E. An Update on PPAR Activation by Cannabinoids. Br. J. Pharmacol. 2016;173:1899&#x2013;1910. doi: 10.1111/bph.13497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13497</ArticleId><ArticleId IdType="pmc">PMC4882496</ArticleId><ArticleId IdType="pubmed">27077495</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi M., Levy R.M. Metaxalone Suppresses Production of Inflammatory Cytokines Associated with Painful Conditions in Mouse Macrophages RAW264.7 Cells in Vitro: Synergistic Effect with &#x3b2;-Caryophyllene. Curr. Mol. Med. 2020;20:643&#x2013;652. doi: 10.2174/1566524020666200217102508.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524020666200217102508</ArticleId><ArticleId IdType="pubmed">32065089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gertsch J., Leonti M., Raduner S., Racz I., Chen J.-Z., Xie X.-Q., Altmann K.-H., Karsak M., Zimmer A. Beta-Caryophyllene Is a Dietary Cannabinoid. Proc. Natl. Acad. Sci. USA. 2008;105:9099&#x2013;9104. doi: 10.1073/pnas.0803601105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803601105</ArticleId><ArticleId IdType="pmc">PMC2449371</ArticleId><ArticleId IdType="pubmed">18574142</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira-Tintino C.D.d.M., Pessoa R.T., Fernandes M.N.M., Alc&#xe2;ntara I.S., da Silva B.A.F., de Oliveira M.R.C., Martins A.O.B.P.B., da Silva M.d.S., Tintino S.R., Rodrigues F.F.G., et al. Anti-Inflammatory and Anti-Edematogenic Action of the Croton Campestris A. St.-Hil (Euphorbiaceae) Essential Oil and the Compound &#x3b2;-Caryophyllene in in Vivo Models. Phytomedicine. 2018;41:82&#x2013;95. doi: 10.1016/j.phymed.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2018.02.004</ArticleId><ArticleId IdType="pubmed">29519324</ArticleId></ArticleIdList></Reference><Reference><Citation>Klauke A.-L., Racz I., Pradier B., Markert A., Zimmer A.M., Gertsch J., Zimmer A. The Cannabinoid CB2 Receptor-Selective Phytocannabinoid Beta-Caryophyllene Exerts Analgesic Effects in Mouse Models of Inflammatory and Neuropathic Pain. Eur. Neuropsychopharmacol. 2014;24:608&#x2013;620. doi: 10.1016/j.euroneuro.2013.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2013.10.008</ArticleId><ArticleId IdType="pubmed">24210682</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly E., Khajah M.A., Masocha W. &#x3b2;-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain. Molecules. 2019;25:106. doi: 10.3390/molecules25010106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25010106</ArticleId><ArticleId IdType="pmc">PMC6983198</ArticleId><ArticleId IdType="pubmed">31892132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Gao Y., Tang S., Lu L., Zhang L., Bu X., Li H., Hu X., Hu X., Jiang P., et al. Large-Scale Network Dysfunction in the Acute State Compared to the Remitted State of Bipolar Disorder: A Meta-Analysis of Resting-State Functional Connectivity. EBioMedicine. 2020;54:102742. doi: 10.1016/j.ebiom.2020.102742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102742</ArticleId><ArticleId IdType="pmc">PMC7136605</ArticleId><ArticleId IdType="pubmed">32259712</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari V.R., Baradaran Rahimi V., Shafiee-Nick R. Low Doses of &#x3b2;-Caryophyllene Reduced Clinical and Paraclinical Parameters of an Autoimmune Animal Model of Multiple Sclerosis: Investigating the Role of CB2 Receptors in Inflammation by Lymphocytes and Microglial. Brain Sci. 2023;13:1092. doi: 10.3390/brainsci13071092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13071092</ArticleId><ArticleId IdType="pmc">PMC10377147</ArticleId><ArticleId IdType="pubmed">37509022</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsey L.P., Daphney C.M., Oppong-Damoah A., Uchakin P.N., Abney S.E., Uchakina O.N., Khusial R.D., Akil A., Murnane K.S. The Cannabinoid Receptor 2 Agonist, &#x3b2;-Caryophyllene, Improves Working Memory and Reduces Circulating Levels of Specific Proinflammatory Cytokines in Aged Male Mice. Behav. Brain Res. 2019;372:112012. doi: 10.1016/j.bbr.2019.112012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.112012</ArticleId><ArticleId IdType="pmc">PMC6650358</ArticleId><ArticleId IdType="pubmed">31173795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez-Hurtado P., Gonz&#xe1;lez-Casta&#xf1;eda R.E., Beas-Zarate C., Flores-Soto M.E., Viveros-Paredes J.M. &#x3b2;-Caryophyllene Reduces DNA Oxidation and the Overexpression of Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus of d-Galactose-Induced Aged BALB/c Mice. J. Med. Food. 2020;23:515&#x2013;522. doi: 10.1089/jmf.2019.0111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2019.0111</ArticleId><ArticleId IdType="pubmed">31663807</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef D.A., El-Fayoumi H.M., Mahmoud M.F. Beta-Caryophyllene Alleviates Diet-Induced Neurobehavioral Changes in Rats: The Role of CB2 and PPAR-&#x3b3; Receptors. Biomed. Pharmacother. 2019;110:145&#x2013;154. doi: 10.1016/j.biopha.2018.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.11.039</ArticleId><ArticleId IdType="pubmed">30469079</ArticleId></ArticleIdList></Reference><Reference><Citation>Segat G.C., Manjavachi M.N., Matias D.O., Passos G.F., Freitas C.S., Costa R., Calixto J.B. Antiallodynic Effect of &#x3b2;-Caryophyllene on Paclitaxel-Induced Peripheral Neuropathy in Mice. Neuropharmacology. 2017;125:207&#x2013;219. doi: 10.1016/j.neuropharm.2017.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.07.015</ArticleId><ArticleId IdType="pubmed">28729222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J., Teng Z., Zhang L., Yang J., Ma L., Wang F., Tian X., An R., Yang M., Zhang Q., et al. &#x3b2;-Caryophyllene/Hydroxypropyl-&#x3b2;-Cyclodextrin Inclusion Complex Improves Cognitive Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 -Mediated Pathway. Front. Pharmacol. 2017;8:2. doi: 10.3389/fphar.2017.00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00002</ArticleId><ArticleId IdType="pmc">PMC5243824</ArticleId><ArticleId IdType="pubmed">28154534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojha S., Javed H., Azimullah S., Haque M.E. &#x3b2;-Caryophyllene, a Phytocannabinoid Attenuates Oxidative Stress, Neuroinflammation, Glial Activation, and Salvages Dopaminergic Neurons in a Rat Model of Parkinson Disease. Mol. Cell. Biochem. 2016;418:59&#x2013;70. doi: 10.1007/s11010-016-2733-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-016-2733-y</ArticleId><ArticleId IdType="pubmed">27316720</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Dong Z., Liu S. &#x3b2;-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPAR&#x3b3; Pathway. Pharmacology. 2014;94:1&#x2013;12. doi: 10.1159/000362689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000362689</ArticleId><ArticleId IdType="pubmed">25171128</ArticleId></ArticleIdList></Reference><Reference><Citation>Poddighe L., Carta G., Serra M.P., Melis T., Boi M., Lisai S., Murru E., Muredda L., Collu M., Banni S., et al. Acute Administration of Beta-Caryophyllene Prevents Endocannabinoid System Activation during Transient Common Carotid Artery Occlusion and Reperfusion. Lipids Health Dis. 2018;17:23. doi: 10.1186/s12944-018-0661-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12944-018-0661-4</ArticleId><ArticleId IdType="pmc">PMC5799897</ArticleId><ArticleId IdType="pubmed">29402275</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed H., Azimullah S., Haque M.E., Ojha S.K. Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson&#x2019;s Disease. Front. Neurosci. 2016;10:321. doi: 10.3389/fnins.2016.00321.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00321</ArticleId><ArticleId IdType="pmc">PMC4969295</ArticleId><ArticleId IdType="pubmed">27531971</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveros-Paredes J.M., Gonz&#xe1;lez-Casta&#xf1;eda R.E., Gertsch J., Chaparro-Huerta V., L&#xf3;pez-Roa R.I., V&#xe1;zquez-Valls E., Beas-Zarate C., Camins-Espuny A., Flores-Soto M.E. Neuroprotective Effects of &#x3b2;-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson&#x2019;s Disease Induced by MPTP. Pharmaceuticals. 2017;10:60. doi: 10.3390/ph10030060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph10030060</ArticleId><ArticleId IdType="pmc">PMC5620604</ArticleId><ArticleId IdType="pubmed">28684694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Ma W., Du J. &#x3b2;-Caryophyllene (BCP) Ameliorates MPP+ Induced Cytotoxicity. Biomed. Pharmacother. 2018;103:1086&#x2013;1091. doi: 10.1016/j.biopha.2018.03.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.03.168</ArticleId><ArticleId IdType="pubmed">29710667</ArticleId></ArticleIdList></Reference><Reference><Citation>Solas M., Francis P.T., Franco R., Ramirez M.J. CB2 Receptor and Amyloid Pathology in Frontal Cortex of Alzheimer&#x2019;s Disease Patients. Neurobiol. Aging. 2013;34:805&#x2013;808. doi: 10.1016/j.neurobiolaging.2012.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.005</ArticleId><ArticleId IdType="pubmed">22763024</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier E.J., Patel S., Hillard C.J. Endocannabinoids in Neuroimmunology and Stress. Curr. Drug Targets CNS Neurol. Disord. 2005;4:657&#x2013;665. doi: 10.2174/156800705774933023.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156800705774933023</ArticleId><ArticleId IdType="pubmed">16375683</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillard C.J. Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia. Curr. Pharm. Des. 2008;14:2347&#x2013;2361. doi: 10.2174/138161208785740054.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161208785740054</ArticleId><ArticleId IdType="pmc">PMC2581413</ArticleId><ArticleId IdType="pubmed">18781985</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang E.-S., Kim H.-B., Lee S., Kim M.-J., Kim K.-J., Han G., Han S.-Y., Lee E.-A., Yoon J.-H., Kim D.-O., et al. Antidepressant-like Effects of &#x3b2;-Caryophyllene on Restraint plus Stress-Induced Depression. Behav. Brain Res. 2020;380:112439. doi: 10.1016/j.bbr.2019.112439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2019.112439</ArticleId><ArticleId IdType="pubmed">31862467</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Oliveira G.L., da Silva J.C.C.L., Dos Santos C L da Silva A.P., Feitosa C.M., de Castro Almeida F.R. Anticonvulsant, Anxiolytic and Antidepressant Properties of the &#x3b2;-Caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems. Curr. Mol. Pharmacol. 2021;14:36&#x2013;51. doi: 10.2174/1874467213666200510004622.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874467213666200510004622</ArticleId><ArticleId IdType="pubmed">32386503</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado K.D.C., Paz M.F.C.J., Oliveira Santos J.V.D., Da Silva F.C.C., Tchekalarova J.D., Salehi B., Islam M.T., Setzer W.N., Sharifi-Rad J., De Castro E Sousa J.M., et al. Anxiety Therapeutic Interventions of &#x3b2;-Caryophyllene: A Laboratory-Based Study. Nat. Prod. Commun. 2020;15 doi: 10.1177/1934578X20962229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X20962229</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdino P.M., Nascimento M.V.M., Florentino I.F., Lino R.C., Fajemiroye J.O., Chaibub B.A., de Paula J.R., de Lima T.C.M., Costa E.A. The Anxiolytic-like Effect of an Essential Oil Derived from Spiranthera Odoratissima A. St. Hil. Leaves and Its Major Component, &#x3b2;-Caryophyllene, in Male Mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;38:276&#x2013;284. doi: 10.1016/j.pnpbp.2012.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2012.04.012</ArticleId><ArticleId IdType="pubmed">22542869</ArticleId></ArticleIdList></Reference><Reference><Citation>Mony T.J., Elahi F., Choi J.W., Park S.J. Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review. Antioxidants. 2022;11:1834. doi: 10.3390/antiox11091834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11091834</ArticleId><ArticleId IdType="pmc">PMC9495487</ArticleId><ArticleId IdType="pubmed">36139909</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.-J., Xuan H.-Z., Shou Q.-Y., Zhan Z.-G., Lu X., Hu F.-L. Therapeutic Effects of Propolis Essential Oil on Anxiety of Restraint-Stressed Mice. Hum. Exp. Toxicol. 2012;31:157&#x2013;165. doi: 10.1177/0960327111412805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0960327111412805</ArticleId><ArticleId IdType="pubmed">21672965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudeep H.V., Venkatakrishna K., Raj A., Reethi B., Shyamprasad K. ViphyllinTM, a Standardized Extract from Black Pepper Seeds, Mitigates Intestinal Inflammation, Oxidative Stress, and Anxiety-like Behavior in DSS-Induced Colitis Mice. J. Food Biochem. 2022;46:e14306. doi: 10.1111/jfbc.14306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.14306</ArticleId><ArticleId IdType="pubmed">35766031</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A., Stewart A., El-Hakim I., Hamilton T.J. Effects of Super-Class Cannabis Terpenes Beta-Caryophyllene and Alpha-Pinene on Zebrafish Behavioural Biomarkers. Sci. Rep. 2022;12:17250. doi: 10.1038/s41598-022-21552-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-21552-2</ArticleId><ArticleId IdType="pmc">PMC9568608</ArticleId><ArticleId IdType="pubmed">36241680</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-&#xc1;vila D.S., Flores-Soto M.E., Tapia-V&#xe1;zquez C., Pastor-Zarandona O.A., L&#xf3;pez-Roa R.I., Viveros-Paredes J.M. &#x3b2;-Caryophyllene, a Natural Sesquiterpene, Attenuates Neuropathic Pain and Depressive-Like Behavior in Experimental Diabetic Mice. J. Med. Food. 2019;22:460&#x2013;468. doi: 10.1089/jmf.2018.0157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2018.0157</ArticleId><ArticleId IdType="pubmed">30864870</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong R.S.Y. Inflammation in COVID-19: From Pathogenesis to Treatment. Int. J. Clin. Exp. Pathol. 2021;14:831&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339720</ArticleId><ArticleId IdType="pubmed">34367415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N.K., Sharma C., Hashiesh H.M., Arunachalam S., Meeran M.N., Javed H., Patil C.R., Goyal S.N., Ojha S. &#x3b2;-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid Can Be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front. Pharmacol. 2021;12:590201. doi: 10.3389/fphar.2021.590201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.590201</ArticleId><ArticleId IdType="pmc">PMC8163236</ArticleId><ArticleId IdType="pubmed">34054510</ArticleId></ArticleIdList></Reference><Reference><Citation>Costiniuk C.T., Jenabian M.-A. Acute Inflammation and Pathogenesis of SARS-CoV-2 Infection: Cannabidiol as a Potential Anti-Inflammatory Treatment? Cytokine Growth Factor. Rev. 2020;53:63&#x2013;65. doi: 10.1016/j.cytogfr.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7239000</ArticleId><ArticleId IdType="pubmed">32467020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarkatti P., Miranda K., Nagarkatti M. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019. Front. Pharmacol. 2020;11:589438. doi: 10.3389/fphar.2020.589438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.589438</ArticleId><ArticleId IdType="pmc">PMC7677512</ArticleId><ArticleId IdType="pubmed">33240092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sexton M. Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. J. Altern. Complement. Med. 2020;26:444&#x2013;448. doi: 10.1089/acm.2020.0144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2020.0144</ArticleId><ArticleId IdType="pubmed">32380847</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj V., Park J.G., Cho K.-H., Choi P., Kim T., Ham J., Lee J. Assessment of Antiviral Potencies of Cannabinoids against SARS-CoV-2 Using Computational and in Vitro Approaches. Int. J. Biol. Macromol. 2021;168:474&#x2013;485. doi: 10.1016/j.ijbiomac.2020.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.12.020</ArticleId><ArticleId IdType="pmc">PMC7836687</ArticleId><ArticleId IdType="pubmed">33290767</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrareddy S.N., Mohan M. SARS-CoV2 Induced Respiratory Distress: Can Cannabinoids Be Added to Anti-Viral Therapies to Reduce Lung Inflammation? Brain Behav. Immun. 2020;87:120&#x2013;121. doi: 10.1016/j.bbi.2020.04.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.079</ArticleId><ArticleId IdType="pmc">PMC7187842</ArticleId><ArticleId IdType="pubmed">32360437</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito G., Pesce M., Seguella L., Sanseverino W., Lu J., Corpetti C., Sarnelli G. The Potential of Cannabidiol in the COVID-19 Pandemic. Br. J. Pharmacol. 2020;177:4967&#x2013;4970. doi: 10.1111/bph.15157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15157</ArticleId><ArticleId IdType="pmc">PMC7300643</ArticleId><ArticleId IdType="pubmed">32519753</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio R., Celenza G., Petricca S. Multi-Target Effects of &#xdf;-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation. Antioxidants. 2022;11:1199. doi: 10.3390/antiox11061199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11061199</ArticleId><ArticleId IdType="pmc">PMC9220155</ArticleId><ArticleId IdType="pubmed">35740096</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Gonz&#xe1;lez I., Madrigal-Bujaidar E., Castro-Garc&#xed;a S. Antigenotoxic Capacity of Beta-Caryophyllene in Mouse, and Evaluation of Its Antioxidant and GST Induction Activities. J. Toxicol. Sci. 2014;39:849&#x2013;859. doi: 10.2131/jts.39.849.</Citation><ArticleIdList><ArticleId IdType="doi">10.2131/jts.39.849</ArticleId><ArticleId IdType="pubmed">25374376</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sotto A., Mazzanti G., Carbone F., Hrelia P., Maffei F. Inhibition by &#x3b2;-Caryophyllene of Ethyl Methanesulfonate-Induced Clastogenicity in Cultured Human Lymphocytes. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 2010;699:23&#x2013;28. doi: 10.1016/j.mrgentox.2010.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrgentox.2010.04.008</ArticleId><ArticleId IdType="pubmed">20398787</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giacomo S., Mazzanti G., Di Sotto A. Mutagenicity of Cigarette Butt Waste in the Bacterial Reverse Mutation Assay: The Protective Effects of &#x3b2;-Caryophyllene and &#x3b2;-Caryophyllene Oxide. Environ. Toxicol. 2016;31:1319&#x2013;1328. doi: 10.1002/tox.22136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.22136</ArticleId><ArticleId IdType="pubmed">25728712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambro&#x17e; M., &#x160;matov&#xe1; M., &#x160;adibolov&#xe1; M., Posp&#xed;&#x161;ilov&#xe1; E., Hadravsk&#xe1; P., Ka&#x161;parov&#xe1; M., Skarkov&#xe1; V.H., Kr&#xe1;lov&#xe1; V., Sk&#xe1;lov&#xe1; L. Sesquiterpenes &#x3b1;-Humulene and &#x3b2;-Caryophyllene Oxide Enhance the Efficacy of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells. Acta Pharm. 2019;69:121&#x2013;128. doi: 10.2478/acph-2019-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/acph-2019-0003</ArticleId><ArticleId IdType="pubmed">31259712</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sheikh S.M.A., Abd El-Alim A.E.-A.F., Galal A.A.A., El-Sayed R.G., El-Naseery N.I. Anti-Arthritic Effect of &#x3b2;-Caryophyllene and Its Ameliorative Role on Methotrexate and/or Leflunomide-Induced Side Effects in Arthritic Rats. Life Sci. 2019;233:116750. doi: 10.1016/j.lfs.2019.116750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116750</ArticleId><ArticleId IdType="pubmed">31408659</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim H.I., Song D.J., Shin C.M., Yoon H., Park Y.S., Kim N., Lee D.H. Inhibitory Effects of &#x3b2;-caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study. Korean J. Gastroenterol. 2019;74:199. doi: 10.4166/kjg.2019.74.4.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.4166/kjg.2019.74.4.199</ArticleId><ArticleId IdType="pubmed">31650795</ArticleId></ArticleIdList></Reference><Reference><Citation>Semprini R., Martorana A., Ragonese M., Motta C. Observational Clinical and Nerve Conduction Study on Effects of a Nutraceutical Combination on Painful Diabetic Distal Symmetric Sensory-Motor Neuropathy in Patients with Diabetes Type 1 and Type 2. Minerva Med. 2018;109:358&#x2013;362. doi: 10.23736/S0026-4806.18.05710-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.18.05710-5</ArticleId><ArticleId IdType="pubmed">30338679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahr T., Allred K., Martinez D., Rodriguez D., Winterton P. Effects of a Massage-like Essential Oil Application Procedure Using Copaiba and Deep Blue Oils in Individuals with Hand Arthritis. Complement. Ther. Clin. Pract. 2018;33:170&#x2013;176. doi: 10.1016/j.ctcp.2018.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctcp.2018.10.004</ArticleId><ArticleId IdType="pubmed">30396617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarumi W., Shinohara K. Olfactory Exposure to &#x3b2;-Caryophyllene Increases Testosterone Levels in Women&#x2019;s Saliva. Sex. Med. 2020;8:525&#x2013;531. doi: 10.1016/j.esxm.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.esxm.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7471126</ArticleId><ArticleId IdType="pubmed">32561330</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos P.S., Oliveira T.C., R J&#xfa;nior L.M., Figueiras A., Nunes L.C.C. &#x3b2;-Caryophyllene Delivery Systems: Enhancing the Oral Pharmacokinetic and Stability. Curr. Pharm. Des. 2018;24:3440&#x2013;3453. doi: 10.2174/1381612824666180912151412.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180912151412</ArticleId><ArticleId IdType="pubmed">30207226</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti T.B., Coelho D.S., Maraschin M. &#x3b2;-Caryophyllene Nanoparticles Design and Development: Controlled Drug Delivery of Cannabinoid CB2 Agonist as a Strategic Tool towards Neurodegeneration. Mater. Sci. Eng. C. 2021;121:111824. doi: 10.1016/j.msec.2020.111824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msec.2020.111824</ArticleId><ArticleId IdType="pubmed">33579467</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;dinger Y., Knaub K., Dharsono T., Wacker R., Meyrat R., Land M.H., Petraglia A.L., Sch&#xf6;n C. Enhanced Oral Bioavailability of &#x3b2;-Caryophyllene in Healthy Subjects Using the VESIsorb&#xae; Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS) Molecules. 2022;27:2860. doi: 10.3390/molecules27092860.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092860</ArticleId><ArticleId IdType="pmc">PMC9104399</ArticleId><ArticleId IdType="pubmed">35566210</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.-X., Artmann C. Relative Bioavailability Comparison of Different Coenzyme Q10 Formulations with a Novel Delivery System. Altern. Ther. Health Med. 2009;15:42&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19284181</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra K.C., Singh B., Pareta S., Kumar K.J. A Validated HPTLC Method for Determination of Trans-Caryophyllene from Polyherbal Formulations. Nat. Prod. Res. 2010;24:1933&#x2013;1938. doi: 10.1080/14786419.2010.497147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2010.497147</ArticleId><ArticleId IdType="pubmed">21108120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Bobadilla M.S., Siepmann F., Djouina M., Dubuquoy L., Tesse N., Willart J.-F., Dubreuil L., Siepmann J., Neut C. Controlled Delivery of a New Broad Spectrum Antibacterial Agent against Colitis: In Vitro and in Vivo Performance. Eur. J. Pharm. Biopharm. 2015;96:152&#x2013;161. doi: 10.1016/j.ejpb.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2015.07.012</ArticleId><ArticleId IdType="pubmed">26209123</ArticleId></ArticleIdList></Reference><Reference><Citation>Geddo F., Scandiffio R., Antoniotti S., Cottone E., Querio G., Maffei M.E., Bovolin P., Gallo M.P. PipeNig&#xae;-FL, a Fluid Extract of Black Pepper (Piper Nigrum L.) with a High Standardized Content of Trans-&#x3b2;-Caryophyllene, Reduces Lipid Accumulation in 3T3-L1 Preadipocytes and Improves Glucose Uptake in C2C12 Myotubes. Nutrients. 2019;11:2788. doi: 10.3390/nu11112788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112788</ArticleId><ArticleId IdType="pmc">PMC6893583</ArticleId><ArticleId IdType="pubmed">31731718</ArticleId></ArticleIdList></Reference><Reference><Citation>Elangovan P., Ramasamy G., Sundaram M., Ramasamy M. Efficacy of Siddha Therapeutics on Mantha Sanni (Autism Spectrum Disorder) Among Pediatric Patients: An Interventional Non-Randomized Open-Label Clinical Trial. Cureus. 2023;15:e47128. doi: 10.7759/cureus.47128.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.47128</ArticleId><ArticleId IdType="pmc">PMC10649252</ArticleId><ArticleId IdType="pubmed">38021630</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>